Literature DB >> 8676694

Delayed reactivation of hepatitis B infection after cladribine.

D P Busuttil, R C Chasty, M Fraser, J A Copplestone, A G Prentice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8676694     DOI： 10.1016/s0140-6736(05)64642-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

2.  Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.

Authors:  Marcello Moccia; Roberta Lanzillo; Antonio Riccardo Buonomo; Giulio Viceconte; Massimiliano Calabrese; Giovanna De Luca; Valentina Tomassini; Paola Cavalla; Giorgia Teresa Maniscalco; Diana Ferraro; Viviana Nociti; Marta Radaelli; Maria Chiara Buscarinu; Damiano Paolicelli; Alberto Gajofatto; Pietro Annovazzi; Federica Pinardi; Massimiliano Di Filippo; Cinzia Cordioli; Emanuela Zappulo; Riccardo Scotto; Ivan Gentile; Antonio Luca Spiezia; Martina Petruzzo; Marcello De Angelis; Vincenzo Brescia Morra; Claudio Solaro; Claudio Gasperini; Eleonora Cocco
Journal:  J Neurol       Date:  2022-02-14       Impact factor: 6.682

Review 3.  The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.

Authors:  Marco Biolato; Assunta Bianco; Matteo Lucchini; Antonio Gasbarrini; Massimiliano Mirabella; Antonio Grieco
Journal:  CNS Drugs       Date:  2021-07-28       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.